These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10357563)

  • 1. Involvement of VEGF and its receptors in ascites tumor formation.
    Shibuya M; Luo JC; Toyoda M; Yamaguchi S
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S72-7. PubMed ID: 10357563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors.
    Luo JC; Yamaguchi S; Shinkai A; Shitara K; Shibuya M
    Cancer Res; 1998 Jun; 58(12):2652-60. PubMed ID: 9635593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
    Luo JC; Toyoda M; Shibuya M
    Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model.
    Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Fukui H
    Hepatology; 2001 Apr; 33(4):841-7. PubMed ID: 11283848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF/Flk-1 interaction, a requirement for malignant ascites recurrence.
    Stoelcker B; Echtenacher B; Weich HA; Sztajer H; Hicklin DJ; Männel DN
    J Interferon Cytokine Res; 2000 May; 20(5):511-7. PubMed ID: 10841080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
    Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
    Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor as a marker of tumor endothelium.
    Brekken RA; Huang X; King SW; Thorpe PE
    Cancer Res; 1998 May; 58(9):1952-9. PubMed ID: 9581838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.
    Warren RS; Yuan H; Matli MR; Gillett NA; Ferrara N
    J Clin Invest; 1995 Apr; 95(4):1789-97. PubMed ID: 7535799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-VEGF receptor complexes as markers of tumor vascular endothelium.
    Brekken RA; Thorpe PE
    J Control Release; 2001 Jul; 74(1-3):173-81. PubMed ID: 11489493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex.
    Cooke SP; Boxer GM; Lawrence L; Pedley RB; Spencer DI; Begent RH; Chester KA
    Cancer Res; 2001 May; 61(9):3653-9. PubMed ID: 11325835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation.
    Verheul HM; Hoekman K; Jorna AS; Smit EF; Pinedo HM
    Oncologist; 2000; 5 Suppl 1():45-50. PubMed ID: 10804091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization.
    Mesiano S; Ferrara N; Jaffe RB
    Am J Pathol; 1998 Oct; 153(4):1249-56. PubMed ID: 9777956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution.
    Pepper MS; Baetens D; Mandriota SJ; Di Sanza C; Oikemus S; Lane TF; Soriano JV; Montesano R; Iruela-Arispe ML
    Dev Dyn; 2000 Jul; 218(3):507-24. PubMed ID: 10878616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis.
    Breier G; Blum S; Peli J; Groot M; Wild C; Risau W; Reichmann E
    Int J Cancer; 2002 Jan; 97(2):142-8. PubMed ID: 11774256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
    Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
    J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
    Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
    Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.